Osteonectin based toxic gene therapy for the treatment of...

A - Human Necessities – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A01N 43/04 (2006.01) A61K 48/00 (2006.01) C12N 15/85 (2006.01)

Patent

CA 2374141

The present invention relates to promoters, enhancers and other regulatory elements that direct expression within tumor and tissue cells with calcification potential. Specifically provided are expression vectors, host cells, and transgenic animals comprising an OSN regulatory region.

La présente invention concerne des promoteurs, des activateurs et d'autres éléments régulateurs qui régulent l'expression dans des cellules de tumeurs et de tissus possédant un potentiel de calcification. L'invention concerne spécifiquement des vecteurs d'expression, des cellules hôtes et des animaux transgéniques comportant une séquence régulatrice de l'ostéonectine (OSN).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Osteonectin based toxic gene therapy for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Osteonectin based toxic gene therapy for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osteonectin based toxic gene therapy for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1370262

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.